Business
Immunic to Participate in Investor and Medical Conferences in May
Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced participation in the following investor and medical conferences in May:
About this update from Immunic, Inc.
[{"type":"text","content":"NEW YORK, April 30, 2026 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced participation in the following investor and medical conferences in May:","length":279,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"May 4-6 and 12-13: 26th Bio€quity Europe. Daniel Vitt, Ph.D., Chief Executive Officer of Immunic, and Jessica Breu, Vice President Investor Relations and Communications at Immunic, will attend and host one-on-one investor meetings at this conference taking place in Prague, Czech Republic and virtually. To schedule a meeting, please use the Bio€quity Europe conference portal or contact Jessica Breu at: [email protected].","length":427,"tagName":"p"}]},{"val":[{"type":"text","content":"May 27-29: 2026 Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting. Members of Immunic's management, medical and preclinical teams will attend this meeting in Charlotte, NC. One late-breaking poster and two additional posters have been accepted for presentation and will be accessible on the "Events and Presentations" section of Immunic's website at: https://ir.imux.com/events-and-presentations. Additionally, the team will be available throughout the event at booth #307.","length":504,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":931,"olType":false},{"type":"text","content":"Late-Breaking Poster Presentation:","length":34,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Title: Novel Unified Statistical Analyses for Confirmed Disability Changes In Multiple Sclerosis for Capturing Possible Neuroprotective Effects","length":143,"tagName":"p"}]},{"val":[{"type":"text","content":"Presenting Author: James Myles, Global Head of Biostatistics at Immunic","length":76,"tagName":"p"}]},{"val":[{"type":"text","content":"Abstract ID: 11244","length":18,"tagName":"p"}]},{"val":[{"type":"text","content":"Poster Board Label: LBA14","length":25,"tagName":"p"}]},{"val":[{"type":"text","content":"Session Date: Thursday, May 28, 2026","length":36,"tagName":"p"}]},{"val":[{"type":"text","content":"Session Time: 5:00-7:00 pm ET","length":29,"tagName":"p"}]},{"val":[{"type":"text","content":"Location: Exhibit Hall","length":22,"tagName...